Literature DB >> 10603105

Liver transplantation in mitochondrial respiratory chain disorders.

E M Sokal1, R Sokol, V Cormier, F Lacaille, P McKiernan, F J Van Spronsen, O Bernard, J M Saudubray.   

Abstract

UNLABELLED: Mitochondrial respiratory chain disease may lead to neonatal or late onset liver failure, requiring liver transplantation. In rare cases, the disease is restricted to the liver and the patient is cured after surgery. More frequently, other organs are simultaneously involved and neuromuscular or other extra-hepatic symptoms may pre-exist, or appear in the post-transplant follow up. Pre-transplant evaluation should aim to rule out neurological disease, which may be difficult to differentiate from signs accompanying liver insufficiency. Cerebrospinal fluid lactic acid levels, compared to blood lactate, may be suggestive of central nervous system involvement. Of 11 cases with respiratory chain disorders who had liver transplantation in various centres, 4 are alive and well on follow up, and 6 died, three of them having developed neurological disease post orthotopic liver transplantation. All three patients with initial liver and gastro-intestinal disease died early after transplantation, indicating that these may be poor candidates for this procedure.
CONCLUSION: Liver transplantation is feasible in hepatic respiratory chain disorders, but extra-hepatic disease should be ruled out before transplantation. Extra-hepatic manifestations may, however, appear and cause patient death despite successful transplantation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10603105     DOI: 10.1007/pl00014328

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  15 in total

Review 1.  Recent advances in pediatric liver transplantation.

Authors:  Debora Kogan-Liberman; Sukru Emre; Benjamin L Shneider
Journal:  Curr Gastroenterol Rep       Date:  2002-02

2.  Mitochondrial respiratory chain hepatopathies: role of liver transplantation. A case series of five patients.

Authors:  Elisabeth De Greef; John Christodoulou; Ian E Alexander; Albert Shun; Edward V O'Loughlin; David R Thorburn; Vicki Jermyn; Michael O Stormon
Journal:  JIMD Rep       Date:  2011-11-04

3.  Reversible fulminant lactic acidosis and liver failure in an infant with hepatic cytochrome-c oxidase deficiency.

Authors:  D Lev; E Gilad; E Leshinsky-Silver; S Houri; A Levine; A Saada; T Lerman-Sagie
Journal:  J Inherit Metab Dis       Date:  2002-09       Impact factor: 4.982

Review 4.  Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management.

Authors:  Kimihiko Oishi; Ronen Arnon; Melissa P Wasserstein; George A Diaz
Journal:  Pediatr Transplant       Date:  2016-06-21

5.  Neonatal liver failure due to deoxyguanosine kinase deficiency.

Authors:  Susana Nobre; Manuela Grazina; Francisco Silva; Carla Pinto; Isabel Gonçalves; Luísa Diogo
Journal:  BMJ Case Rep       Date:  2012-04-02

6.  Liver transplantation and cell therapies for inborn errors of metabolism.

Authors:  Patrick McKiernan
Journal:  J Inherit Metab Dis       Date:  2013-01-08       Impact factor: 4.982

7.  Valproic acid-associated acute liver failure in children: case report and analysis of liver transplantation outcomes in the United States.

Authors:  Ayse L Mindikoglu; Dale King; Laurence S Magder; John A Ozolek; George V Mazariegos; Benjamin L Shneider
Journal:  J Pediatr       Date:  2010-12-16       Impact factor: 4.406

8.  Liver transplantation for inborn errors of liver metabolism.

Authors:  Efienne M Sokal
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

Review 9.  Therapies in inborn errors of oxidative metabolism.

Authors:  Manuel Schiff; Paule Bénit; Howard T Jacobs; Jerry Vockley; Pierre Rustin
Journal:  Trends Endocrinol Metab       Date:  2012-05-25       Impact factor: 12.015

10.  Mitochondrial hepatopathies: advances in genetics, therapeutic approaches, and outcomes.

Authors:  Way Seah Lee; Ronald J Sokol
Journal:  J Pediatr       Date:  2013-06-28       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.